Transfection Reagents and Equipment Market
  • Published Date: Aug-2021
  • |
  • 180 Pages
  • |
  • Report ID: HE0245

Transfection Reagents and Equipment Market

Transfection Reagents and Equipment market is expected to grow from USD 10.46 billion in 2019 to USD 17.87 billion by 2026 at a CAGR of 7.95% from 2020 to 2026.

  • Report Description
  • Table of Content
  • Segmentation
  • Companies
  • News

Transfection is a technique that is employed to insert genetic material like DNA or RNA, into mammalian cells. Transfection reagents and equipment are utilized in this process, wherein reagents contain the genetic material and equipment used as a delivery for the genetic material. This introduction of genetic material into the specified cells are often administered by various chemical, biological, or physical methods. The growth of the market is often attributed to increasing technological advancements in transfections equipment and rising research and development spending alongside research activities by pharmaceutical and biotechnology companies. Moreover, rising demand for synthetic genes is probably going to feature new opportunities for the worldwide market within the forecast period. This growth is often attributed to factors like advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, the development of huge scale transfections, rising demand for protein therapeutics, and emerging markets across India and China are likely to make opportunities for players operating within the market. The global market is segregated on the basis of Product as Reagents and Instruments. Based on Method the global market is segmented in Biochemical, Calcium Phosphate, Lipofection, DEAE-dextran, Dendrimers, Physical, Electroporation, Nucleofection, and Others. Based on End User the global market is segmented in Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. Based on Application, the global market is segmented in Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production, and Therapeutic Delivery.

The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Thermo Fisher Scientific Inc. (Life Technologies), Promega Corporation, Qiagen N.V., F. Hoffmann-La Roche Ltd, Bio–Rad Laboratories, Inc., Maxcyte, Inc., Lonza Group Ltd., Merck KGaA, Polyplus-Transfection Sa, Mirus Bio LLC., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Transfection Reagents and Equipment market has been segmented as below:

By Product

  • Reagents
  • Instruments

By Method

  • Biochemical
  • Calcium Phosphate
  • Lipofection
  • DEAE-dextran
  • Dendrimers
  • Physical
  • Electroporation
  • Nucleofection
  • Others

By End-User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

By Application

  • Biomedical Research
  • Gene Expression Studies
  • Cancer Research
  • Transgenic Model
  • Protein Production
  • Therapeutic Delivery

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

By Company

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Hoffmann-La Roche Ltd
  • Bio–Rad Laboratories, Inc.
  • Maxcyte, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Polyplus-Transfection Sa
  • Mirus Bio LLC.
  • Danaher
  • Agilent Technologies
  • Illumina, Inc.
  • Norgen Biotek Corp.
  • PerkinElmer Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

The report covers the below scope:

  • Global market sizes from 2020 to 2026, along with CAGR for 2020-2026
  • Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021, and forecast from 2022 to 2026
  • Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
  • Major market opportunities and challenges in the forecast timeframe to be focused
  • Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year - 2022
  • Forecast period - 2022 to 2026

Report Scope:

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Thermo Fisher Scientific Inc. (Life Technologies), Promega Corporation, Qiagen N.V., F. Hoffmann-La Roche Ltd, Bio–Rad Laboratories, Inc., Maxcyte, Inc., Lonza Group Ltd., Merck KGaA, Polyplus-Transfection Sa, Mirus Bio LLC., and others.

Why Buy this Report:

  • Gain detailed insights on the Transfection Reagents and Equipment industry trends
  • Find a complete analysis of the market status
  • Identify the market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

                        4.2.2 Restraints

                        4.2.3 Opportunities

                        4.2.4 Challenges

            4.2 Porter's Five Force Analysis

  1. By Product

            5.1 Introduction

            5.2 Reagents

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Instruments

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

  1. By Method

            6.1 Introduction

            6.2 Biochemical

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Calcium Phosphate

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

            6.4 Lipofection

                        6.4.1 Market Overview

                        6.4.2 Market Size and Forecast

            6.5 DEAE-dextran

                        6.5.1 Market Overview

                        6.5.2 Market Size and Forecast

            6.6 Dendrimers

                        6.6.1 Market Overview

                        6.6.2 Market Size and Forecast

            6.7 Physical

                        6.7.1 Market Overview

                        6.7.2 Market Size and Forecast

            6.8 Electroporation

                        6.8.1 Market Overview

                        6.8.2 Market Size and Forecast

            6.9 Nucleofection

                        6.9.1 Market Overview

                        6.9.2 Market Size and Forecast

            6.10 Others

                        6.10.1 Market Overview

                        6.10.2 Market Size and Forecast

  1. By End-User

            7.1 Introduction

            7.2 Academic & Research Institutes

                        7.2.1 Market Overview

                        7.2.2 Market Size and Forecast

            7.3 Pharmaceutical & Biotechnology Companies

                        7.3.1 Market Overview

                        7.3.2 Market Size and Forecast

  1. By Application

            8.1 Introduction

            8.2 Biomedical Research

                        8.2.1 Market Overview

                        8.2.2 Market Size and Forecast

            8.3 Gene Expression Studies

                        8.3.1 Market Overview

                        8.3.2 Market Size and Forecast

            8.4 Cancer Research

                        8.4.1 Market Overview

                        8.4.2 Market Size and Forecast

            8.5 Transgenic Model

                        8.5.1 Market Overview

                        8.5.2 Market Size and Forecast

            8.6 Protein Production

                        8.6.1 Market Overview

                        8.6.2 Market Size and Forecast

            8.7 Therapeutic Delivery

                        8.7.1 Market Overview

                        8.7.2 Market Size and Forecast

  1. By Geography

            9.1 Introduction

            9.2 Europe

                        9.2.1 Europe Market, By Product

                        9.2.2 Europe Market, By Method

                        9.2.3 Europe Market, By End User

                        9.2.4 Europe Market, By Application

            9.3 North America

                        9.3.1 North America Market, By Product

                        9.3.2 North America Market, By Method

                        9.3.3 North America Market, By End User

                        9.3.4 North America Market, By Application

            9.4 Asia Pacific

                        9.4.1 Asia Pacific Market, By Product

                        9.4.2 Asia Pacific Market, By Method

                        9.4.3 Asia Pacific Market, By End User

                        9.4.4 Asia Pacific Market, By Application

            9.5 Rest of The World

                        9.5.1 Rest of The World Market, By Product

                        9.5.2 Rest of The World Market, By Method

                        9.5.3 Rest of The World Market, By End User

                        9.5.4 Rest of The World Market, By Application

  1. Competitive Insights

            10.1 Key Insights

            10.2 Company Market Share Analysis

            10.3 Strategic Outlook

                        10.3.1 Mergers & Acquisitions

                        10.3.2 New Product Development

                        10.3.3 Portfolio/Production Capacity Expansions

                        10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        10.3.5 Others

  1. Company Profiles

(Overview, Key Financials, Recent Developments, Product and Service Offering)

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Hoffmann-La Roche Ltd
  • Bio–Rad Laboratories, Inc.
  • Maxcyte, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Polyplus-Transfection Sa
  • Mirus Bio LLC.
  • Danaher
  • Agilent Technologies
  • Illumina, Inc.
  • Norgen Biotek Corp.
  • PerkinElmer Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc

The global Transfection Reagents and Equipment market has been segmented as below:

By Product

  • Reagents
  • Instruments

By Method

  • Biochemical
  • Calcium Phosphate
  • Lipofection
  • DEAE-dextran
  • Dendrimers
  • Physical
  • Electroporation
  • Nucleofection
  • Others

By End-User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

By Application

  • Biomedical Research
  • Gene Expression Studies
  • Cancer Research
  • Transgenic Model
  • Protein Production
  • Therapeutic Delivery

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

By Company

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Hoffmann-La Roche Ltd
  • Bio–Rad Laboratories, Inc.
  • Maxcyte, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Polyplus-Transfection Sa
  • Mirus Bio LLC.
  • Danaher
  • Agilent Technologies
  • Illumina, Inc.
  • Norgen Biotek Corp.
  • PerkinElmer Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

License Options

  • Single 1500 USD
  • Multiple 3000 USD